Literature DB >> 26331537

Cancer: Mutant p53 and chromatin regulation.

Carol Prives1, Scott W Lowe2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26331537      PMCID： PMC4683398          DOI： 10.1038/nature15212

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  14 in total

Review 1.  The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis.

Authors:  Ali Shilatifard
Journal:  Annu Rev Biochem       Date:  2012       Impact factor: 23.643

Review 2.  p53 function and dysfunction.

Authors:  B Vogelstein; K W Kinzler
Journal:  Cell       Date:  1992-08-21       Impact factor: 41.582

3.  Mutant p53 cooperates with ETS2 to promote etoposide resistance.

Authors:  Phi M Do; Lakshman Varanasi; Songqing Fan; Chunyang Li; Iwona Kubacka; Virginia Newman; Krishna Chauhan; Silvano Rakeem Daniels; Maurizio Boccetta; Michael R Garrett; Runzhao Li; Luis A Martinez
Journal:  Genes Dev       Date:  2012-04-15       Impact factor: 11.361

4.  Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.

Authors:  William A Freed-Pastor; Hideaki Mizuno; Xi Zhao; Anita Langerød; Sung-Hwan Moon; Ruth Rodriguez-Barrueco; Anthony Barsotti; Agustin Chicas; Wencheng Li; Alla Polotskaia; Mina J Bissell; Timothy F Osborne; Bin Tian; Scott W Lowe; Jose M Silva; Anne-Lise Børresen-Dale; Arnold J Levine; Jill Bargonetti; Carol Prives
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

Review 5.  Illuminating p53 function in cancer with genetically engineered mouse models.

Authors:  Patty B Garcia; Laura D Attardi
Journal:  Semin Cell Dev Biol       Date:  2014-01-03       Impact factor: 7.727

Review 6.  Mutant p53: one name, many proteins.

Authors:  William A Freed-Pastor; Carol Prives
Journal:  Genes Dev       Date:  2012-06-15       Impact factor: 11.361

7.  Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signaling.

Authors:  Susann Weissmueller; Eusebio Manchado; Michael Saborowski; John P Morris; Elvin Wagenblast; Carrie A Davis; Sung-Hwan Moon; Neil T Pfister; Darjus F Tschaharganeh; Thomas Kitzing; Daniela Aust; Elke K Markert; Jianmin Wu; Sean M Grimmond; Christian Pilarsky; Carol Prives; Andrew V Biankin; Scott W Lowe
Journal:  Cell       Date:  2014-04-10       Impact factor: 41.582

Review 8.  p53 mutations in cancer.

Authors:  Patricia A J Muller; Karen H Vousden
Journal:  Nat Cell Biol       Date:  2013-01       Impact factor: 28.824

Review 9.  The many facets of MLL1 regulation.

Authors:  Pamela Zhang; Elisa Bergamin; Jean-François Couture
Journal:  Biopolymers       Date:  2013-02       Impact factor: 2.505

10.  Structural basis for understanding oncogenic p53 mutations and designing rescue drugs.

Authors:  Andreas C Joerger; Hwee Ching Ang; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205
View more
  13 in total

1.  Comparison of human lung cancer cell radiosensitivity after irradiations with therapeutic protons and carbon ions.

Authors:  Otilija D Keta; Danijela V Todorović; Tanja M Bulat; Pablo Ga Cirrone; Francesco Romano; Giacomo Cuttone; Ivan M Petrović; Aleksandra M Ristić Fira
Journal:  Exp Biol Med (Maywood)       Date:  2016-09-15

2.  Aberrant expression of ETS1 and ETS2 proteins in cancer.

Authors:  Elizabeth A Fry; Kazushi Inoue
Journal:  Cancer Rep Rev       Date:  2018-04-23

Review 3.  Molecularly targeted therapies for p53-mutant cancers.

Authors:  Dekuang Zhao; William M Tahaney; Abhijit Mazumdar; Michelle I Savage; Powel H Brown
Journal:  Cell Mol Life Sci       Date:  2017-06-22       Impact factor: 9.261

4.  Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5.

Authors:  Fotini Vogiatzi; Dominique T Brandt; Jean Schneikert; Jeannette Fuchs; Katharina Grikscheit; Michael Wanzel; Evangelos Pavlakis; Joël P Charles; Oleg Timofeev; Andrea Nist; Marco Mernberger; Eva J Kantelhardt; Udo Siebolts; Frank Bartel; Ralf Jacob; Ariane Rath; Roland Moll; Robert Grosse; Thorsten Stiewe
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-12       Impact factor: 11.205

5.  Genetic differences among ethnic groups.

Authors:  Tao Huang; Yang Shu; Yu-Dong Cai
Journal:  BMC Genomics       Date:  2015-12-21       Impact factor: 3.969

Review 6.  Mutant p53 and ETS2, a Tale of Reciprocity.

Authors:  Luis Alfonso Martinez
Journal:  Front Oncol       Date:  2016-02-18       Impact factor: 6.244

Review 7.  Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex.

Authors:  Giovanna Carrà; Sabrina Crivellaro; Riccardo Taulli; Angelo Guerrasio; Giuseppe Saglio; Alessandro Morotti
Journal:  Int J Mol Sci       Date:  2016-11-29       Impact factor: 5.923

8.  NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinoma.

Authors:  Vera Tiedje; Saskia Ting; Thomas Herold; Sarah Synoracki; Soeren Latteyer; Lars C Moeller; Denise Zwanziger; Martin Stuschke; Dagmar Fuehrer; Kurt Werner Schmid
Journal:  Oncotarget       Date:  2017-06-27

9.  Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.

Authors:  Nitish Kumar Mishra; Chittibabu Guda
Journal:  Oncotarget       Date:  2017-04-25

10.  Frame-shift mediated reduction of gain-of-function p53 R273H and deletion of the R273H C-terminus in breast cancer cells result in replication-stress sensitivity.

Authors:  Viola Ellison; George K Annor; Clara Freedman; Gu Xiao; Devon Lundine; Elzbieta Freulich; Carol Prives; Jill Bargonetti
Journal:  Oncotarget       Date:  2021-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.